
GRAIL INC
GRAL · NASDAQ
Updated at 2026-10-19 00:24:17
- Today's High
- $136.50
- Today’s Low
- $117.06
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $134.02
- Previous Close
- $117.81
- Volume
- 1.3M
- Market Cap
- $5.26B
- P/E Ratio
- --
- EPS
- $-9.74
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- DIAGNOSTICS & RESEARCH
- Headquarters
- 1525 O?BRIEN DRIVE, MENLO PARK, CA, UNITED STATES, 94025
- Country
- US
- Listing Date
- 2024-06-12
- Fiscal Year End
- December
- Shares Outstanding
- 42.92M
- CIK
- 0001699031
- Website
- grail.com
GRAIL, LLC is a leading biotechnology firm specializing in advanced cancer diagnostics, particularly through its innovative blood tests designed for multi-cancer early detection (MCED). Utilizing proprietary genomic technologies, the company is committed to enhancing precision medicine by offering vital insights for proactive health management and improving patient outcomes. GRAIL is poised to address critical gaps in cancer screening and diagnostics, establishing itself as a pivotal entity in the dynamic oncology landscape, with the potential to significantly impact the future of cancer care.
Financial Metrics
Revenue
2026-06-30
$44.68M
2026-03-31
$40.78M
2025-12-31
$43.59M
2025-09-30
$36.19M
Operating Expenses
2026-06-30
$161.21M
2026-03-31
$155.3M
2025-12-31
$113.27M
2025-09-30
$111.55M
Net Income
2026-06-30
-$110.24M
2026-03-31
-$93.18M
2025-12-31
-$99.17M
2025-09-30
-$88.97M
Net Profit Margin
2026-06-30
-246.7%
2026-03-31
-228.48%
2025-12-31
-227.48%
2025-09-30
-245.83%
Earnings Per Share
2026-06-30
$-2.56
2026-03-31
$-1.37
2025-12-31
$-2.44
2025-09-30
$-2.46
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$128.02M
2026-03-31
-$88.72M
2025-12-31
-$77.61M
2025-09-30
-$79.73M
Effective Tax Rate
2026-06-30
33.86%
2026-03-31
26.92%
2025-12-31
14.88%
2025-09-30
25.05%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $44.68M | $40.78M | $43.59M | $36.19M |
| Operating Expenses | $161.21M | $155.3M | $113.27M | $111.55M |
| Net Income | -$110.24M | -$93.18M | -$99.17M | -$88.97M |
| Net Profit Margin | -246.7% | -228.48% | -227.48% | -245.83% |
| Earnings Per Share | $-2.56 | $-1.37 | $-2.44 | $-2.46 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$128.02M | -$88.72M | -$77.61M | -$79.73M |
| Effective Tax Rate | 33.86% | 26.92% | 14.88% | 25.05% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.